miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2. This evidence concerns the gene CDK2 and Carcinoma, Lewis Lung.